Insulin-dependent signaling pathways are often overactivated in human HCC due to the overexpression of signaling components and loss of negative regulators (Alqahtani et al, 2019; Enguita-German and Fortes, 2014). The gene discussed is INS; the disease is hepatocellular carcinoma.